依沙吖啶宫腔注入法治疗胎盘植入的临床观察  

Clinical analysis of injection ethacridin in uterine cavity to treat placenta accreta

作　　者：刘晓燕[1] 姜云霞[1] 隋延霞[1] 

机构地区：[1]威海市文登中心医院妇产科,山东省威海264400

出　　处：《中国基层医药》2006年第9期1419-1420,共2页Chinese Journal of Primary Medicine and Pharmacy

摘　　要：目的观察用依沙吖啶(利凡诺)宫腔注入法治疗胎盘植入的效果。方法将我院1999年1月至2005年1月不需手术可以保守治疗的胎盘植入40例,随机分为两组,研究组采用依沙吖啶宫腔注入法治疗,对照组采用氨甲蝶呤静脉滴注治疗,观察其疗效及不良反应。结果人绒毛膜促性腺激素β亚单位(β-hCG)下降时间及胎盘排出时间两组差异无统计学意义(P>0·05)。出现黏膜炎症的患者研究组0例,对照组7例,差异有统计学意义(P<0·05);白细胞下降低于正常的患者,研究组1例,对照组8例,差异有统计学意义(P<0·05)。结论依沙吖啶宫腔注入法治疗胎盘植入简单方便,安全有效,不良反应少,值得推广。Objective To observe the effectiveness of injection ethacridin in uterine cavity to treat placenta accreta. Methods From 1999 to 2005,40 patients treated by conservative treatment were derided into two groups. The study group was treated by injection ethacridin in uterine cavity, The control group was treated by iv drip the MTX. Then those effectiveness and side effect were observed. Results The fall time of β-hCG and the discharge time of placenta had not significant difference（P 〉 0-05 ）. Patients with mucitis of the study group and the control group were 0 and 7. The difference in statistics analysis was significant（P 〈 0.05）;One patient with falling of the white blood cell in the study group and eight in the control group. The difference was notable（ P 〈 0.05 ）. Conclusion Injection ethacridin in uterine cavity to treat placenta accreta is simple and facilitate,safe and validity,and the side effect is little. It is worthy to be extended.

关 键 词：胎盘 侵入性 依沙吖啶 注射 药物疗法 

分 类 号：R714.462[医药卫生—妇产科学]